Since September 1987, all patients under 46 years admitted to our Hospital with cerebral infarcts (Cl), the cause of which was unknown, have undergone complete hematological screening (partial thromboplastin time; prothrombin ratio; fibrinogen level; lupus anticoagulant activity; fibrinolytic capacity; proteins C and S; antilhrom- bin III; AT-III, and hemoglobin electrophoresis when indicated). In 2 out of 22 patients admitted in 1988, sickle cell trait and AT-III deficiency were the only abnormalities identified. We conclude that complete hematological screening should be carried out in every young patient with Cl when more common causes are not present. © 1991 S. Karger AG, Basel.
|Publication status||Published - 1 Jan 1991|
- Antithrombin III, deficiency of
- Ischemic stroke in young
- Sickle cell trait